Pasithea Therapeutics Corp. Just Filed Its Quarterly Report: Net Loss Per ShareNe... - Nov. 13, 2023
Annual Report to Security Holders - Oct. 26, 2023
Pasithea Therapeutics Corp. releases salary data. CEO sees compensation fall -19% - Oct. 26, 2023
Other preliminary proxy statements - Oct. 16, 2023
Shareholder Director - Oct. 13, 2023
Tender offer statement by Issuer - Sept. 14, 2023
Pasithea Therapeutics Corp. Announces Final Results Of Tender Offer - Sept. 14, 2023
Tender offer statement by Issuer - Aug. 24, 2023
Tender offer statement by Issuer - Aug. 21, 2023
Tender offer statement by Issuer - Aug. 14, 2023
Pasithea Therapeutics Corp. Just Filed Its Quarterly Report: Net Loss Per ShareNe... - Aug. 11, 2023
Tender offer statement by Issuer - Aug. 9, 2023
Pasithea Therapeutics Announces Intention To Commence A $4.0 Million - July 20, 2023
Written communication relating to an issuer or third party - July 20, 2023
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - July 20, 2023
Lawrence Steinman just provided an update on activist position in Pasithea Therapeutics Corp. - June 8, 2023
Pasithea Therapeutics Corp. just filed a prospectus, suggesting it plans to soon issue some securities - June 6, 2023
Pasithea Therapeutics Corp. director just picked up 30,000 shares - June 6, 2023
Pasithea Therapeutics Corp. director just declared owning 1,282,174 shares of Pasithea Therapeutics Corp. - June 6, 2023
Notice of Effectiveness - June 5, 2023
Pasithea Therapeutics Corp. Just Filed Its Quarterly Report: Net Loss Per Share N... - May 12, 2023
Registration statement under Securities Act of 1933 - May 12, 2023
Notice of Effectiveness - April 19, 2023
Annual report [Section 13 and 15(d), not S-K Item 405] - April 4, 2023
Pasithea Therapeutics Corp. Just Filed Its Annual Report: Net Loss Per Share N... - March 30, 2023
Registration statement under Securities Act of 1933 - March 30, 2023
Securities to be offered to employees in employee benefit plans - March 30, 2023
Pasithea Therapeutics - March 10, 2023
Major owner of Pasithea Therapeutics Corp. just declared owning 2,608,696 shares of Pasithea Therapeutics Corp. - Feb. 14, 2023
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Jan. 24, 2023
Uday Khire just provided an update on share ownership of Pasithea Therapeutics Corp. - Jan. 13, 2023
General statement of acquisition of beneficial ownership - Jan. 10, 2023
Pasithea Therapeutics: Press Release Dated December 12, 2022 - Dec. 14, 2022
Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - Dec. 7, 2022
Pasithea Therapeutics Corp. just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 30, 2022
Pasithea Therapeutics Corp. just filed a prospectus, suggesting it plans to soon issue some securities - Nov. 30, 2022
Pasithea Therapeutics: Soliciting Material Under 240.14A-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION - Nov. 29, 2022
Pasithea Therapeutics Corp.'s Chief Executive Officer just picked up 9,206 shares - Nov. 28, 2022
Pasithea Therapeutics Corp. director just picked up 5,000 shares - Nov. 28, 2022
Pasithea Therapeutics: Securities Exchange Act Of 1934 - Nov. 28, 2022
Pasithea Therapeutics Corp. director just picked up 5,000 shares - Nov. 22, 2022
Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - Nov. 22, 2022
Definitive proxy statement, contested solicitations - Nov. 17, 2022
Pasithea Therapeutics Corp. director just picked up 50,000 shares - Nov. 17, 2022
Definitive proxy statement, contested solicitations - Nov. 15, 2022
Pasithea Therapeutics Corp. Just Filed Its Quarterly Report: Net Loss Per Share N... - Nov. 14, 2022
Preliminary Proxy Soliciting materials - Nov. 14, 2022
Preliminary proxy statements, contested solicitations - Nov. 1, 2022
General statement of acquisition of beneficial ownership - Nov. 1, 2022
Other preliminary proxy statements - Oct. 31, 2022
Pasithea Therapeutics Corp. director just picked up 5,000 shares - Oct. 26, 2022
Pasithea Therapeutics Corp. director was just granted 100,000 options - Oct. 24, 2022
Pasithea Therapeutics Corp.'s Chief Executive Officer just picked up 5,000 shares - Oct. 21, 2022
Uday Khire just provided an update on share ownership of Pasithea Therapeutics Corp. - Oct. 20, 2022
Pasithea Therapeutics Corp. insider just picked up 1,000 shares - Oct. 19, 2022
Pasithea Therapeutics Corp. director just picked up 10,000 shares - Oct. 17, 2022
Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - Oct. 13, 2022
Pasithea Therapeutics Corp.'s Chief Financial Officer was just granted 300,000 options - Oct. 12, 2022
Non-management revised preliminary proxy soliciting materials, contested and otherwise - Oct. 12, 2022
Pasithea Therapeutics: Press Release Dated October 12, 2022 - Oct. 12, 2022
Pasithea Therapeutics Corp. insider just picked up 64,357 shares - Sept. 30, 2022
Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - Sept. 29, 2022
Preliminary proxy statements, contested solicitations - Sept. 23, 2022
Securities to be offered to employees in employee benefit plans - Sept. 21, 2022
Departure of Directors or Certain - Sept. 20, 2022
Pasithea Therapeutics Corp. director just declared ownership of no shares of Pasithea Therapeutics Corp. - Sept. 20, 2022
Pasithea Therapeutics Corp. just filed a prospectus, suggesting it plans to soon issue some securities - Sept. 16, 2022
Pasithea Therapeutics Corp. just filed a prospectus, suggesting it plans to soon issue some securities - Sept. 16, 2022
Pasithea Therapeutics Corp. insider just picked up 88,901 shares - Sept. 6, 2022
Eric Shahinian just provided an update on activist position in Pasithea Therapeutics Corp. - Sept. 6, 2022
Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - Sept. 6, 2022
Eric Shahinian just provided an update on activist position in Pasithea Therapeutics Corp. - Sept. 1, 2022
Pasithea Therapeutics Corp. insider just picked up 22,828 shares - Aug. 31, 2022
Pasithea Therapeutics: Notes To The Financial Statements REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Aug. 29, 2022
Pasithea Therapeutics Corp. insider just picked up 54,644 shares - Aug. 26, 2022
Pasithea Therapeutics Corp. insider just declared ownership of no shares of Pasithea Therapeutics Corp. - Aug. 26, 2022
Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - Aug. 24, 2022
Pasithea Therapeutics Corp. insider just picked up 155,773 shares - Aug. 18, 2022
Pasithea Therapeutics: Soliciting Material Under 240.14A-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION - Aug. 18, 2022
Pasithea Therapeutics Corp. insider just declared owning 226,521 shares of Pasithea Therapeutics Corp. - Aug. 16, 2022
Major owner of Pasithea Therapeutics Corp. just declared owning 1,034,702 shares of Pasithea Therapeutics Corp. - Aug. 15, 2022
Pasithea Therapeutics Corp. insider just declared owning 1,455,556 shares of Pasithea Therapeutics Corp. - Aug. 15, 2022
Pasithea Therapeutics Corp.'s Interim Chief Accting Officer just declared ownership of no shares of Pasithea Therapeutics Corp. - Aug. 15, 2022
Pasithea Therapeutics: (Exact Name Of Registrant As Specified In Its Charter) - Aug. 11, 2022
Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - Aug. 5, 2022
Pasithea Therapeutics: Securities Exchange Act Of 1934 - Aug. 2, 2022
General statement of acquisition of beneficial ownership - July 28, 2022
Definitive proxy statement, contested solicitations - July 28, 2022
Preliminary proxy statements, contested solicitations - July 26, 2022
Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material - July 26, 2022
Other preliminary proxy statements - July 15, 2022
Definitive proxy statement, contested solicitations - July 14, 2022
Non-management revised preliminary proxy soliciting materials, contested and otherwise - July 13, 2022
Preliminary proxy statements, contested solicitations - July 1, 2022
Pasithea Therapeutics Corp. director just picked up 10,000 shares - June 30, 2022
PD Joint Holdings, LLC, Series just provided an update on share ownership of Pasithea Therapeutics Corp. - June 29, 2022
Financial Statements and - June 27, 2022
Pasithea Therapeutics Corp. director just picked up 5,000 shares - June 27, 2022
Submission of Matters to a Vote of Security - June 24, 2022
